Carlyle Leads USD47m Series A for China’s BiOligo
Source(s): The Carlyle Group
The Carlyle Group, through its Carlyle Beijing Partners Fund II, led a ~USD47m Series A for BiOligo, a China-based in vitro diagnostics raw material supplier. Read more
Source(s): The Carlyle Group
The Carlyle Group, through its Carlyle Beijing Partners Fund II, led a ~USD47m Series A for BiOligo, a China-based in vitro diagnostics raw material supplier. Read more